Intravitreous Injections of Pegaptanib (Macugen) May Help Prevent Further Vision Loss From Central Retinal Vein Occlusion
Links shared publicly online about this topic.
- 2,072total visits
Intravitreous Injections of Pegaptanib (Macugen) May Help Prevent Further Vision Loss From Central Retinal Vein Occlusion
As recently reported in MedPage Today, a study published in the April 2009 issue of The Archives of Ophthalmology, researchers have found that intravitreous
View full resource at eyedocnews.com
Tags: Circulation, Vision, Ophthalmology
Most Recently Shared on May 3, 2009 at 4:47 am By:
Discuss: Intravitreous Injections of Pegaptanib (Macugen) May Help Prevent Further Vision Loss From Cent.. http://tinyurl.com/dj5bta
Medical News: Intravitreous Pegaptanib Could Halt Vision Loss - in Ophthalmology, Ophthalmology from MedPage Today
medpagetoday.com — “SAN FRANCISCO -- Intravitreous injection of pegaptanib (Macugen) may help prevent further vision loss from central retinal vein occlusion but does little to reverse it, researchers found.” View full resource at medpagetoday.com
Most Recently Shared on April 17, 2009 at 8:42 pm By:
Intravitreous Pegaptanib Could Halt CRVO Vision Loss http://medpagetoday.com/13802
Advertisement
